Biblio Discovery — Demo Discovery Service

47 results for "Burhan, Erlina"

Showing 1–20 · 0.50 seconds · RSS

  1. Journal Article Full text

    Supporting progress towards the post-2015 targets and regional tuberculosis elimination: a statement of intent from the third meeting of the Asian TB Experts Community

    Mori, Toru; Burhan, Erlina

    Eur Respir J · 2015 · English · PubMed Central

    In the first concerted Asian reaction to the post-2015 strategy the significance of TB screening was recognised http://ow.ly/LnWPW

  2. Journal Article Full text

    Molecular Diagnosis of Tuberculosis

    Nurwidya, Fariz; Handayani, Diah; Burhan, Erlina et al.

    Chonnam Med J · 2018 · English · PubMed Central

    Tuberculosis (TB) is one of the leading causes of adult death in the Asia-Pacific Region, including Indonesia. As an infectious disease caused by Mycobacterium tuberculosis (MTB), TB remains a major public health issue especially in developing nations due to the lack of adequate diagnostic testing…

  3. Journal Article Full text

    Tuberculosis Elimination in the Asia-Pacific Region and the WHO Ethics Guidance

    Denholm, Justin T.; Silva, Diego S.; Burhan, Erlina et al.

    Trop Med Infect Dis · 2018 · English · PubMed Central

    The World Health Organization has produced ethical guidance on implementation of the End TB strategy, which must be considered in local context. The Asia-Pacific Region has important distinctive characteristics relevant to tuberculosis, and engagement with the ethical implications raised is…

  4. Journal Article Full text

    Emotional freedom techniques for elderly patients with COVID-19: a case series on clinical recovery, frailty, and inflammatory biomarkers

    Kemala Sari, Nina; Burhan, Erlina; Isbaniah, Fathiyah et al.

    Front Psychol · 2025 · English · PubMed Central

    BACKGROUND/OBJECTIVES: Older adults are disproportionately affected by COVID-19 due to immunosenescence and comorbidities, resulting in higher rates of severe illness and mortality. Psychological distress such as anxiety and fatigue further compounds disease burden. Emotional Freedom Techniques…

  5. Journal Article Full text

    Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios

    Fuady, Ahmad; Houweling, Tanja A. J.; Mansyur, Muchtaruddin et al.

    Infect Dis Poverty · 2019 · English · PubMed Central

    BACKGROUND: The World Health Organization’s End Tuberculosis Strategy states that no tuberculosis (TB)-affected households should endure catastrophic costs due to TB. To achieve this target, it is essential to provide adequate social protection. As only a few studies in many countries have…

  6. Journal Article Full text

    Cost of seeking care for tuberculosis since the implementation of universal health coverage in Indonesia

    Fuady, Ahmad; Houweling, Tanja A. J.; Mansyur, Muchtaruddin et al.

    BMC Health Serv Res · 2020 · English · PubMed Central

    BACKGROUND: Although tuberculosis (TB) patients often incur high costs to access TB-related services, it was unclear beforehand whether the implementation of universal health coverage (UHC) in Indonesia in 2014 would reduce direct costs and change the pattern of care-seeking behaviour. After its…

  7. Journal Article Full text

    Catastrophic costs due to tuberculosis worsen treatment outcomes: a prospective cohort study in Indonesia

    Fuady, Ahmad; Houweling, Tanja A J; Mansyur, Muchtaruddin et al.

    Trans R Soc Trop Med Hyg · 2020 · English · PubMed Central

    BACKGROUND: While the incidence of catastrophic costs due to tuberculosis (TB) remains high, there is little evidence about their impact on TB treatment outcomes and adherence. We assessed their effect on treatment outcomes and adherence in Indonesia. METHODS: We interviewed 282 adult TB patients…

  8. Journal Article Full text

    Risk factors for viral hepatitis in pulmonary tuberculosis patients undergoing treatment: A systematic review and meta-analysis

    Ilham, Ahmad F.; Andini, Salsabila R.; Afladhia, Hanna L. et al.

    Narra J · 2024 · English · PubMed Central

    Liver injury in tuberculosis patients, associated with noncompliance with treatment, is further exacerbated by viral hepatitis, which not only directly harms the liver but also increases susceptibility to drug-induced liver injury. The aim of this study was to analyze the associated risk factors…

  9. Journal Article Full text

    771. Drug Resistance Tuberculosis (DR-TB), Comorbidities and Risk Factors Identified in a Prospective Multicenter Cohort Study in Indonesia

    Burhan, Erlina; Wibisono, Banteng; Indah, Retna et al.

    Open Forum Infect Dis · 2018 · English · PubMed Central

    BACKGROUND: The numbers of patients with drug resistance TB (DR-TB) increased annually by over 20% globally in the last decade. However, data on the prevalence of DR-TB in Indonesia are limited. The objective of this study to estimate the proportion of DR-TB in new and previously treated TB cases…

  10. Journal Article Full text

    How do private general practitioners manage tuberculosis cases? A survey in eight cities in Indonesia

    Mahendradhata, Yodi; Lestari, Trisasi; Probandari, Ari et al.

    BMC Res Notes · 2015 · English · PubMed Central

    BACKGROUND: Private practitioners (PPs) in high-burden countries often provide substandard tuberculosis (TB) treatment, leading to increased risk of drug resistance and continued transmission. TB case management among PPs in Indonesia has not been investigated in recent years, despite longstanding…

  11. Journal Article Full text

    Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19

    Prasenohadi, Prasenohadi; Burhan, Erlina; Dhunny, Sri et al.

    J Clin Med · 2022 · English · PubMed Central

    Humanized Virus Suppressing Factor-variant 13 (hzVSF-v13), a monoclonal IgG4 antibody against vimentin, was investigated in moderate to severe COVID-19 pneumonia through a Phase II study. Patients were randomized to two different IV doses of the test drug or saline with standard of care. Overall…

  12. Journal Article Full text

    Shortened Telomere Length as a Risk Factor for Idiopathic Pulmonary Fibrosis: A Meta-Analysis

    Fachrucha, Fanny; Syuaib, Farhana Ibrahim; Purwono, Arini et al.

    Open Respir Med J · 2026 · English · PubMed Central

    BACKGROUND: Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease with limited life expectancy after diagnosis. The median survival time ranges from 2 to 4 years, indicating a poor prognosis. Multiple telomere-related genes that cause telomere shortening have been associated with a…

  13. Journal Article Full text

    Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients

    Burhan, Erlina; Ruesen, Carolien; Ruslami, Rovina et al.

    Antimicrob Agents Chemother · 2013 · English · PubMed Central

    Numerous studies have reported low concentrations of antituberculosis drugs in tuberculosis (TB) patients, but few studies have examined whether low drug concentrations affect TB treatment response. We examined steady-state plasma concentrations of isoniazid, rifampin, and pyrazinamide at 2 h after…

  14. Journal Article Full text

    Telomere shortening correlates with immune dysregulation and severity in pulmonary tuberculosis

    Fachrucha, Fanny; Andarini, Sita; Burhan, Erlina et al.

    BMC Pulm Med · 2026 · English · PubMed Central

    BACKGROUND: Telomere shortening is suspected to influence the severity of inflammation and tissue damage in tuberculosis. This study aims to analyze the association between telomere length and inflammatory cytokines in tuberculosis patients. METHODS: The study was conducted at Persahabatan National…

  15. Journal Article Full text

    Endobronchial Ultrasonography Features in Tuberculous Mediastinal Lymphadenopathy

    Desianti, Ginanjar Arum; Rasmin, Menaldi; Lisnawati, Lisnawati et al.

    Tuberc Respir Dis (Seoul) · 2025 · English · PubMed Central

    BACKGROUND: Mediastinal lymphadenopathy indicates an intrathoracic pathological process. Tuberculous mediastinal lymphadenopathy (TML) can be an early sign of tuberculosis infection, particularly in developing countries. Its incidence is often unclear due to underdiagnosis and limited access to…

  16. Journal Article Full text

    Chronic Pulmonary Aspergillosis in Post Tuberculosis Patients in Indonesia and the Role of LDBio Aspergillus ICT as Part of the Diagnosis Scheme

    Rozaliyani, Anna; Rosianawati, Harmi; Handayani, Diah et al.

    J Fungi (Basel) · 2020 · English · PubMed Central

    Chronic pulmonary aspergillosis (CPA) is a common sequela of pulmonary tuberculosis (TB). The diagnosis of CPA is difficult and often misdiagnosed as smear-negative TB in endemic settings. Aspergillus IgG detection is the cornerstone of CPA diagnosis. There are a lack of studies on the prevalence…

  17. Journal Article Full text

    Association between cardiovascular diseases and COVID-19 pneumonia outcome in Indonesia: a multi-center cohort study

    Burhan, Erlina; Mubarak, Farhan; Adilah, Siti Aliyah Said Utriyani et al.

    Front Med (Lausanne) · 2023 · English · PubMed Central

    BACKGROUND: COVID-19 is a pandemic affecting 185 countries, including Indonesia. Cardiovascular diseases (CVD) in COVID-19 patients were linked to worse clinical outcomes. However, the association remained inconclusive due to limited data in Indonesia. This study aimed to determine the association…

  18. Journal Article Full text

    Real-World Effectiveness of COVID-19 Vaccines (ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2) in Jakarta: Protocol for Test-Negative Design of Health Care Data

    Burhan, Erlina; Azzumar, Farchan; Sinuraya, Fira Alyssa Gabriella et al.

    JMIR Res Protoc · 2025 · English · PubMed Central

    BACKGROUND: ChAdOx-1s, CoronaVac, BBIBP-CorV, mRNA-1273, and BNT162b2 are the five common COVID-19 vaccines used in Jakarta. Randomized controlled trials have provided robust evidence of the safety and efficacy profile of these vaccines, but their real-world vaccine effectiveness against…